Comparative study of midterm outcomes between Roux-en-Y gastric bypass (RYGB), diverted one-anastomosis gastric bypass (D-OAGB), and one anastomosis gastric bypass (OAGB) - Scorecard - MDSpire

Comparative study of midterm outcomes between Roux-en-Y gastric bypass (RYGB), diverted one-anastomosis gastric bypass (D-OAGB), and one anastomosis gastric bypass (OAGB)

  • By

  • Mohamed Abdul Moneim El Masry

  • Islam Abdul Rahman

  • Mohamed Fathy Mahmoud Elshal

  • Ahmed Maher Abdul Moneim

  • November 9, 2024

  • 0 min

Share

Clinical Scorecard: Midterm Outcome Comparisons of Roux-en-Y Gastric Bypass, Diverted One-Anastomosis Gastric Bypass, and One-Anastomosis Gastric Bypass

At a Glance

CategoryDetail
ConditionObesity and obesity-related medical conditions
Key MechanismsMetabolic/bariatric surgery inducing weight loss and metabolic improvements via gastric bypass and intestinal bypass components
Target PopulationPatients eligible for bariatric surgery per IFSO guidelines
Care SettingSurgical bariatric centers with multidisciplinary evaluation

Key Highlights

  • Roux-en-Y gastric bypass (RYGB) and one-anastomosis gastric bypass (OAGB) are effective bariatric procedures with metabolic benefits.
  • OAGB offers a simpler surgical approach with potentially greater malabsorptive effects due to a longer biliopancreatic limb.
  • Diverted OAGB (D-OAGB) modifies OAGB by adding Roux-en-Y diversion to reduce bile reflux and marginal ulcers.

Guideline-Based Recommendations

Diagnosis

  • Patient eligibility for bariatric surgery should follow International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) guidelines.
  • GERD diagnosis postoperatively is based on typical symptoms and/or ongoing use of proton pump inhibitors beyond 3 months.

Management

  • Selection of bariatric procedure (RYGB, OAGB, or D-OAGB) should be individualized after patient-surgeon discussion of benefits and risks.
  • Surgical techniques include creation of gastric pouch and intestinal limb lengths specific to each procedure.
  • Intraoperative methylene blue test is recommended to detect anastomotic leakage.

Monitoring & Follow-up

  • Follow-up includes assessment of weight loss at 3, 6 months, and beyond using total weight loss percentage (TWL%) and excess weight loss percentage (EWL%).
  • Monitor improvement of obesity-related conditions by reduction or cessation of medications for hypertension, diabetes, and dyslipidemia.
  • Evaluate GERD symptoms and treatment status postoperatively to assess improvement or persistence.

Risks

  • Biliary reflux is a known complication of OAGB, potentially requiring surgical revision.
  • D-OAGB aims to reduce bile reflux risk by creating a Roux-en-Y configuration.
  • Perioperative adverse events should be monitored and managed accordingly.

Patient & Prescribing Data

Patients undergoing bariatric bypass surgeries (RYGB, OAGB, D-OAGB) with at least 2 years follow-up

Weight loss and metabolic improvements are achieved with all procedures; D-OAGB may reduce bile reflux complications compared to OAGB.

Clinical Best Practices

  • Ensure thorough preoperative multidisciplinary evaluation and informed consent discussing procedure-specific risks and benefits.
  • Use standardized surgical techniques with appropriate limb lengths and anastomosis methods to optimize outcomes.
  • Employ intraoperative leak testing to reduce postoperative complications.
  • Conduct regular postoperative follow-up to monitor weight loss, metabolic improvements, and GERD symptoms.
  • Consider D-OAGB as an alternative to OAGB to minimize bile reflux while maintaining weight loss efficacy.

References

Original Source(s)

Related Content